EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α‐Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots

Mukesh Gabhane, Raji Patil, Shruti Dharmadhikari, Priyank Shah, Chintan Khandhedia, Suyog Mehta

Journal of Cosmetic Dermatology · 2025

DOI: 10.1111/jocd.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Mukesh Gabhane und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ex-Employee, Medical Affairs, Sun Pharma Laboratories Limited, Mumbai, India. Hauptthemen laut MEDLINE: Arbutin, Facial Dermatoses, Glucosides, Hydroxybenzoates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Skin hyperpigmentation is a dermatological concern for pigmented skin phototypes. Despite availability of multiple treatment options, hyperpigmentation management continues to be a challenge.

Aims

Efficacy and safety assessment of the skincare regimen [topical formulation of trihydroxybenzoic acid glucoside 10% (THBG) and α‐arbutin 2% (twice‐daily) + sunscreen (once daily)] in Indian females with pigmentary spots (facial dark spots or melasma).

Methods

This prospective, open‐label, single‐arm, interventional study was conducted in Indian females ( n = 124), aged 18–45 years, having FitzPatrick skin type III–IV, dull skin, and facial dark spots or melasma. Efficacy of 90‐day skincare regimen was evaluated using mexameter, modified melasma area and severity index (mMASI) score, cross‐polarized light photography, chromameter, and color–luminosity–brightness–transparency (CLBT) technique. Student's t ‐test (paired data) was used for statistical analysis.

Results

In efficacy analysis [modified intention‐to‐treat (mITT) population], 120 subjects were included. Melanin content of pigmentary spots (on mexametry) significantly reduced (−16.3%, p < 0.001) at Day 90 versus baseline. Significant reduction in severity of melasma was observed (−18.4% in mMASI score) at Day 90. Significant improvement in ΔEab (−8.7%) (change in color difference between pigmentary spot and normal skin) on cross‐polarized photographs, in skin‐brightening parameters L * (relative brightness/lightness) (−2.7%), ITA° (individual typology angle) (−37.7%), and Δ E * (skin‐tone evenness) (−19.0%) using chromameter. Significant improvement in skin radiance was observed in CLBT parameters, color (pink: 32.8%, yellow: –5.5%, and olive: −7.8%), luminosity (6.0%), brightness (4.6%), and transparency (0.2%). Regimen did not cause itching, burning, or irritation.

Conclusions

Skincare regime of 10% THBG and 2% α‐arbutin along with sunscreen was effective in reducing pigmentary spots (dark spots and melasma) and was well tolerated in Indian women. Trial Registration: Clinical Trial Registry of India (CTRI Reg. No. CTRI/2021/11/038345; date: 30/11/2021)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArbutinFacial DermatosesGlucosidesHydroxybenzoatesMelanosisSunscreening AgentsAdolescentAdultFemaleHumansMiddle AgedYoung AdultAdministration, CutaneousDrug CombinationsFaceIndiaProspective StudiesSeverity of Illness IndexSkin PigmentationTreatment OutcomeSouth Asian People

Stichwörter der Autor:innen

dark spotshyperpigmentationmelanin contentmelasmatrihydroxybenzoic acid glucosideα‐arbutin

Substanzen

ArbutinDrug CombinationsGlucosidesHydroxybenzoatesSunscreening Agents

Autor:innen und Institutionen

  • Ex-Employee, Medical Affairs, Sun Pharma Laboratories Limited, Mumbai, India.
  • Dermatologist, Mascot Spincontrol India Pvt. Ltd., Mumbai, India.
  • Medical Affairs, Sun Pharma Laboratories Limited, Mumbai, India.

Zitieren

APA

Gabhane, M., Patil, R., Dharmadhikari, S., Shah, P., Khandhedia, C., & Mehta, S. (2025). Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α‐Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70017

Vancouver

Gabhane M, Patil R, Dharmadhikari S, Shah P, Khandhedia C, Mehta S. Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α‐Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70017

BibTeX
@article{Gabhane2025,
  author = {Gabhane, Mukesh and Patil, Raji and Dharmadhikari, Shruti and Shah, Priyank and Khandhedia, Chintan and Mehta, Suyog},
  title = {Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α‐Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots},
  journal = {Journal of Cosmetic Dermatology},
  year = {2025},
  doi = {10.1111/jocd.70017}
}
Kostenlos starten →